drugset / Trial / NCT05514353
A Phase 1 Study to Assess Single and Multiple Ascending Doses of PBI-100 Topical Cream
RandomizedSequentialDouble-blindTreatment
Summary
This is a Phase 1, randomized, double-blind, vehicle-controlled, SAD / MAD study evaluating three dose levels of PBI-100 topical cream in healthy adult volunteers and/or subjects with psoriasis.
Timeline
- Start
- 2021-12-28
- Primary completion
- 2023-01-12
- Completion
- 2023-01-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PBI-100 | Unknown | — | Topical |